Evidence map›Paper›PMID 38136440›Full record

ArticleCancers2023

Feasibility Study Utilizing NanoString's Digital Spatial Profiling (DSP) Technology for Characterizing the Immune Microenvironment in Barrett's Esophagus Formalin-Fixed Paraffin-Embedded Tissues.

Qurat-Ul-Ain, Nicola F Frei, Amir M Khoshiwal, Pim Stougie, Robert Odze, Sophie Camilleri-Broet, Lorenzo Ferri, Lucas C Duits, Jacques Bergman, Matthew D Stachler

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Pathogenesis of Barrett's Esophagus: Evolving and Emerging Mechanisms.Gastrointestinal endoscopy clinics of North America · 2026
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Qurat-Ul-AinDepartment of Pathology, University of California, San Francisco, CA 94143, USA.ORCID 0000-0003-4092-6900
Nicola F FreiAmsterdam UMC Locatie AMC, 1105 AZ Amsterdam, The Netherlands.ORCID 0000-0002-5358-2767
Amir M KhoshiwalAmsterdam UMC Locatie AMC, 1105 AZ Amsterdam, The Netherlands.
Pim StougieAmsterdam UMC Locatie AMC, 1105 AZ Amsterdam, The Netherlands.
Robert OdzeDepartment of Pathology, School of Medicine, Tufts University, Boston, MA 02111, USA.
Sophie Camilleri-BroetDivision of Thoracic and Upper Gastrointestinal Surgery, Montreal General Hospital, McGill University, Montreal, QC H3G 1A4, Canada.
Lorenzo FerriDivision of Thoracic and Upper Gastrointestinal Surgery, Montreal General Hospital, McGill University, Montreal, QC H3G 1A4, Canada.ORCID 0000-0003-3275-2584
Lucas C DuitsAmsterdam UMC Locatie AMC, 1105 AZ Amsterdam, The Netherlands.ORCID 0000-0002-5995-121X
Jacques BergmanAmsterdam UMC Locatie AMC, 1105 AZ Amsterdam, The Netherlands.
Matthew D StachlerDepartment of Pathology, University of California, San Francisco, CA 94143, USA.ORCID 0000-0003-0958-0286
Amsterdam University Medical Centers · NLMontreal General Hospital · CAUniversity of California, San Francisco · USTufts University · US

Funding

Optimization and validation of a biomarker panel for risk stratification in Barrett's esophagusR37CA269649 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Matthew D Stachler · 2023 to 2026
$2.6M
Early TP53 Mutations and Genomic Doubling as a Novel Path for Barrett's Esophagus ProgressionK08DK109209 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STACHLER, MATTHEW D · 2016 to 2021
$929k
NCI NIH HHS R37 CA269649NIDDK NIH HHS K08 DK109209
6 · The paper itself

Abstract

Characterization of the Barrett's esophagus (BE) microenvironment in patients with a known progression status, to determine how it may influence BE progression to esophageal adenocarcinoma (EAC), has been understudied, hindering both the biological understanding of the progression and the development of novel diagnostics and therapies. This study's aim was to determine if a highly multiplex interrogation of the microenvironment can be performed on endoscopic formalin-fixed, paraffin-embedded (FFPE) samples, utilizing the NanoString GeoMx digital spatial profiling (GeoMx DSP) platform and if it can begin to identify the types of immune cells and pathways that may mediate the progression of BE. We performed a spatial proteomic analysis of 49 proteins expressed in the microenvironment and epithelial cells of FFPE endoscopic biopsies from patients with non-dysplastic BE (NDBE) who later progressed to high-grade dysplasia or EAC

Indexed as

Barrett’s esophagusesophageal adenocarcinomaimmune profilingspatial proteomicsspatial transcriptomicstumor microenvironment

Identifiers

PMID38136440
PMCPMC10742302
OpenAlexW4389914218

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.